Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.

Press/Media: Research

PeriodSept 11 2023 → Sept 12 2023

Media coverage

3

Media coverage

  • Title-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date9/12/23
    PersonsCarman Anthony Giacomantonio
  • Title-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date9/12/23
    PersonsCarman Anthony Giacomantonio
  • TitleSona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.
    Media name/outletFinancial News Releases
    Country/TerritoryCanada
    Date9/11/23
    PersonsCarman Anthony Giacomantonio